Epstein Secrets

% 12.0% 11.1% 2006 NA 20.2% 13.5% 5.0% 9.1% 27.2% 11.7% 12.2% Average 13.8% 2007 -44% 18.2% 18.1% 6.0% 17.4% 29.4% 10.8% 13.0% Medlin 12.6% 2008 -7244 23.0% 124% 3.3% 12.9% 26.7% 8.8% 7.0% 2009 49% 20.6% 6.3% 0.4% 193% 23.8% 6.8% 5.7% 2010 0.2% 18.3% 5.6% 9.3

000 and risk of all sorts (including lack of marketability) was being penalized at increasing levels in the marketplace. is From John D. Emory Sr., F.R. Dengel 111, and John D. Emory Jr., 'Expanded Study of the Value of Marketability as Illustrated in Initial Public Offerings of Common Stock; May 1997 throu

% 12.0% 11.1% 2006 NA 20.2% 13.5% 5.0% 9.1% 27.2% 11.7% 12.2% Average 13.8% 2007 -44% 18.2% 18.1% 6.0% 17.4% 29.4% 10.8% 13.0% Medlin 12.6% 2008 -7244 23.0% 124% 3.3% 12.9% 26.7% 8.8% 7.0% 2009 49% 20.6% 6.3% 0.4% 193% 23.8% 6.8% 5.7% 2010 0.2% 18.3% 5.6% 9.3

000 and risk of all sorts (including lack of marketability) was being penalized at increasing levels in the marketplace. is From John D. Emory Sr., F.R. Dengel 111, and John D. Emory Jr., 'Expanded Study of the Value of Marketability as Illustrated in Initial Public Offerings of Common Stock; May 1997 throu

% 12.0% 11.1% 2006 NA 20.2% 13.5% 5.0% 9.1% 27.2% 11.7% 12.2% Average 13.8% 2007 -44% 18.2% 18.1% 6.0% 17.4% 29.4% 10.8% 13.0% Medlin 12.6% 2008 -7244 23.0% 124% 3.3% 12.9% 26.7% 8.8% 7.0% 2009 49% 20.6% 6.3% 0.4% 193% 23.8% 6.8% 5.7% 2010 0.2% 18.3% 5.6% 9.3

000 and risk of all sorts (including lack of marketability) was being penalized at increasing levels in the marketplace. is From John D. Emory Sr., F.R. Dengel 111, and John D. Emory Jr., 'Expanded Study of the Value of Marketability as Illustrated in Initial Public Offerings of Common Stock; May 1997 throu